Ferring Fights To Revive Drug IP Inventorship Dispute
A Federal Circuit panel on Thursday questioned why Ferring Pharmaceuticals waited seven years to challenge the inventorship of three patents that an ex-employee sold to Allergan in a $43 million deal...To view the full article, register now.
Already a subscriber? Click here to view full article